Albert Bourla

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Pfizer Inc Jan. 1, 2020 -
Chief Executive Officer, Director Pfizer Inc Oct. 1, 2018 - Jan. 1, 2020
Chief Operating Officer, Director Pfizer Inc Feb. 22, 2018 - Oct. 1, 2018
Chief Operating Officer Pfizer Inc Jan. 1, 2018 - Feb. 22, 2018
Group President - Pfizer Innovative Health Pfizer Inc June 1, 2016 - Jan. 1, 2018
Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business Pfizer Inc Feb. 8, 2016 - June 1, 2016
Group President - Vaccines, Oncology and Consumer Healthcare Business Pfizer Inc Jan. 1, 2014 - Feb. 8, 2016
Albert Bourla's trades of Pfizer Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Pfizer Inc (PFE)
Transaction date
Purchase
Price
458.03
Quantity 77,715 -45.6%
Value US$4,660,034
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
310.88
Quantity 56,443 +3.0%
Value US$2,042,352
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-12
US Pfizer Inc (PFE)
B Purchase
77,715 -45.6%
458.03
US$4,660,034 		77,715 -45.6% 458.03 US$4,660,034
2020-11-10 2020-11-09
US Pfizer Inc (PFE)
PlS Planned sale
56,443 +3.0%
310.88
US$2,042,352 		56,443 +3.0% 310.88 US$2,042,352